Alterations of hemostasis associated with cardiopulmonary bypass.
D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000097:blood*; D001792:Blood Platelets; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D005338:Fibrin Fibrinogen Degradation Products / Q000097:blood; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000032:analysis; D006400:Hematocrit; D006487:Hemostasis; D006801:Humans; D010958:Plasminogen / Q000032:analysis; D010973:Platelet Adhesiveness; D011479:Protamines / Q000494:pharmacology; D011517:Prothrombin Time; D013917:Thrombin / Q000032:analysis; D013997:Time Factors
D005338:Fibrin Fibrinogen Degradation Products; D011479:Protamines; D005340:Fibrinogen; D010958:Plasminogen; D013917:Thrombin; D005341:Fibrinolysin